Author:
Li Yingying,Lin Mengmeng,Cao Bo,Xu Jing,Xiao Xiaohe,Li Guohui,Li Chunyu
Publisher
Science China Press., Co. Ltd.
Reference33 articles.
1. Wu H, Zhong Q, Wang J. Beneficial effects and toxicity studies of Xian-ling-gu-bao on bone metabolism in ovariectomized rats. Front Pharmacol, 2017, 8:
2. Li Z R, Cheng L M, Wang K Z. Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head—A first multicentre, randomised, double-blind, placebo-controlled clinical trial. J Orthop Transl, 2018, 12: 36-44.
3. Du Q, Wang Z, Yun N R, et al. Literature analysis of 185 cases of ADR induced by Xianling Gubao capsule (in Chinese). China Pharm, 2017, 28: 3785–3787 [杜倩, 王哲, 运乃茹, 等. 仙灵骨葆胶囊致不良反应185例文献分析. 中国药房, 2017, 28: 3785–3787].
4. Li C, Niu M, Liu Y. Screening for susceptibility-related factors and biomarkers of Xianling Gubao capsule-induced liver injury. Front Pharmacol, 2020, 11:
5. Kullak-Ublick G A, Andrade R J, Merz M. Drug-induced liver injury: Recent advances in diagnosis and risk assessment. Gut, 2017, 66: 1154-1164.